BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kain V, Jadapalli JK, Tourki B, Halade GV. Inhibition of FPR2 impaired leukocytes recruitment and elicited non-resolving inflammation in acute heart failure. Pharmacol Res 2019;146:104295. [PMID: 31216426 DOI: 10.1016/j.phrs.2019.104295] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Yarmohammadi F, Hayes AW, Karimi G. Possible protective effect of resolvin D1 on inflammation in atrial fibrillation: involvement of ER stress mediated the NLRP3 inflammasome pathway. Naunyn Schmiedebergs Arch Pharmacol 2021;394:1613-9. [PMID: 34216224 DOI: 10.1007/s00210-021-02115-0] [Reference Citation Analysis]
2 Liu L, Yu Y, Hu LL, Dong QB, Hu F, Zhu LJ, Liang Q, Yu LL, Bao HH, Cheng XS. Potential Target Genes in the Development of Atrial Fibrillation: A Comprehensive Bioinformatics Analysis. Med Sci Monit 2021;27:e928366. [PMID: 33741890 DOI: 10.12659/MSM.928366] [Reference Citation Analysis]
3 Guo S, Wu J, Zhou W, Liu X, Liu Y, Zhang J, Jia S, Li J, Wang H. Identification and analysis of key genes associated with acute myocardial infarction by integrated bioinformatics methods. Medicine (Baltimore) 2021;100:e25553. [PMID: 33847684 DOI: 10.1097/MD.0000000000025553] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Luo SD, Chiu TJ, Chen WC, Wang CS. Sex Differences in Otolaryngology: Focus on the Emerging Role of Estrogens in Inflammatory and Pro-Resolving Responses. Int J Mol Sci 2021;22:8768. [PMID: 34445474 DOI: 10.3390/ijms22168768] [Reference Citation Analysis]
5 Li S, Li A, Zhai L, Sun Y, Yu L, Fang Z, Zhang L, Peng Y, Zhang M, Wang X. Suppression of FPR2 expression inhibits inflammation in preeclampsia by improving the biological functions of trophoblast via NF-κB pathway. J Assist Reprod Genet 2022. [PMID: 35018584 DOI: 10.1007/s10815-022-02395-2] [Reference Citation Analysis]
6 Tourki B, Kain V, Shaikh SR, Leroy X, Serhan CN, Halade GV. Deficit of resolution receptor magnifies inflammatory leukocyte directed cardiorenal and endothelial dysfunction with signs of cardiomyopathy of obesity. FASEB J 2020;34:10560-73. [PMID: 32543720 DOI: 10.1096/fj.202000495RR] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
7 Miao Z, Schultzberg M, Wang X, Zhao Y. Role of polyunsaturated fatty acids in ischemic stroke - A perspective of specialized pro-resolving mediators. Clin Nutr 2021;40:2974-87. [PMID: 33509668 DOI: 10.1016/j.clnu.2020.12.037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Maciuszek M, Cacace A, Brennan E, Godson C, Chapman TM. Recent advances in the design and development of formyl peptide receptor 2 (FPR2/ALX) agonists as pro-resolving agents with diverse therapeutic potential. Eur J Med Chem 2021;213:113167. [PMID: 33486199 DOI: 10.1016/j.ejmech.2021.113167] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
9 Caso VM, Manzo V, Pecchillo Cimmino T, Conti V, Caso P, Esposito G, Russo V, Filippelli A, Ammendola R, Cattaneo F. Regulation of Inflammation and Oxidative Stress by Formyl Peptide Receptors in Cardiovascular Disease Progression. Life (Basel) 2021;11:243. [PMID: 33804219 DOI: 10.3390/life11030243] [Reference Citation Analysis]
10 Kain V, Halade GV. Role of neutrophils in ischemic heart failure. Pharmacol Ther 2020;205:107424. [PMID: 31629005 DOI: 10.1016/j.pharmthera.2019.107424] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
11 Wickstead ES, Irving MA, Getting SJ, McArthur S. Exploiting formyl peptide receptor 2 to promote microglial resolution: a new approach to Alzheimer's disease treatment. FEBS J 2021. [PMID: 33811735 DOI: 10.1111/febs.15861] [Reference Citation Analysis]
12 Wickstead ES, Karim HA, Manuel RE, Biggs CS, Getting SJ, McArthur S. Reversal of β-Amyloid-Induced Microglial Toxicity In Vitro by Activation of Fpr2/3. Oxid Med Cell Longev 2020;2020:2139192. [PMID: 32617132 DOI: 10.1155/2020/2139192] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Salazar J, Pirela D, Nava M, Castro A, Angarita L, Parra H, Durán-Agüero S, Rojas-Gómez DM, Galbán N, Añez R, Chacín M, Diaz A, Villasmil N, De Sanctis JB, Bermúdez V. Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis. Int J Mol Sci 2022;23:3133. [PMID: 35328553 DOI: 10.3390/ijms23063133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Maciuszek M, Ortega-Gomez A, Maas SL, Garrido-Mesa J, Ferraro B, Perretti M, Merritt A, Nicolaes GAF, Soehnlein O, Chapman TM. Design, synthesis, and biological evaluation of novel pyrrolidinone small-molecule Formyl peptide receptor 2 agonists. Eur J Med Chem 2021;226:113805. [PMID: 34536667 DOI: 10.1016/j.ejmech.2021.113805] [Reference Citation Analysis]
15 Ma Y. Role of Neutrophils in Cardiac Injury and Repair Following Myocardial Infarction. Cells 2021;10:1676. [PMID: 34359844 DOI: 10.3390/cells10071676] [Reference Citation Analysis]
16 Kain V, Halade GV. Dysfunction of resolution receptor triggers cardiomyopathy of obesity and signs of non-resolving inflammation in heart failure. Mol Cell Endocrinol 2021;542:111521. [PMID: 34843898 DOI: 10.1016/j.mce.2021.111521] [Reference Citation Analysis]
17 Maciuszek M, Ortega-Gomez A, Maas SL, Perretti M, Merritt A, Soehnlein O, Chapman TM. Synthesis and evaluation of novel cyclopentane urea FPR2 agonists and their potential application in the treatment of cardiovascular inflammation. Eur J Med Chem 2021;214:113194. [PMID: 33548634 DOI: 10.1016/j.ejmech.2021.113194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Tourki B, Halade GV. Heart Failure Syndrome With Preserved Ejection Fraction Is a Metabolic Cluster of Non-resolving Inflammation in Obesity. Front Cardiovasc Med 2021;8:695952. [PMID: 34409075 DOI: 10.3389/fcvm.2021.695952] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]